Genetic Background Strongly Influences the Impact of Carrying the Thr92Ala-DIO2 Polymorphism in the Male Mouse
Endocrinology · 2024
DOI: 10.1210/endocr/bqae064 ↗Kurz gefasst
Fachartikel in der Zeitschrift Endocrinology, 2024. Verfasst von Guilherme Gabriel de Almeida und 5 weiteren Autor:innen. Beteiligte Einrichtung: Section of Adult and Pediatric Endocrinology, Diabetes & Metabolism, University of Chicago Medical Center, Chicago, IL 60637, USA. Hauptthemen laut MEDLINE: Iodothyronine Deiodinase Type II, Polymorphism, Genetic. Die Arbeit wurde bisher 7-mal zitiert (Crossref) und nennt 48 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: NIDDK NIH HHS, Fundação à Pesquisa do Estado de São Paulo, PROEX.
Abstract (Originalsprache)
About half of the world population carries at least one allele of the Ala92-DIO2, which slows down the activity of the type 2 deiodinase (D2), the enzyme that activates T4 to T3. Carrying the Ala92-DIO2 allele has been associated with increased body mass index and insulin resistance, but this has not been reproduced in all populations. To test if the genetic background affects the impact of this polymorphism, here we studied the genetically distant C57Bl/6J (B6) and FVB/N (FVB) mice carrying the Ala92-Dio2 allele as compared to control mice carrying the Thr92-Dio2 allele. Whereas B6-Ala92-Dio2 and B6-Thr92-Dio2 mice—fed chow or high-fat diet—behaved metabolically similar in studies using indirect calorimetry, glucose- and insulin tolerance tests, and measuring white adipose tissue (WAT) weight and liver steatosis, major differences were observed between FVB-Ala92-Dio2 and FVB-Thr92-Dio2 mice: carrying the Ala92-Dio2 allele (on a chow diet) resulted in hypercholesterolemia, smaller WAT pads, hepatomegaly, steatosis, and transcriptome changes in the interscapular brown adipose tissue (iBAT) typical of ER stress and apoptosis. Acclimatization at thermoneutrality (30 °C) eliminated most of the metabolic phenotype, indicating that impaired adaptive (BAT) thermogenesis can be involved. In conclusion, the metabolic impact of carrying the Ala92-Dio2 allele depends greatly on the genetic background of the mouse, varying from no phenotype in B6 mice to a major phenotype in FVB mice. These results will help the planning of future clinical trials studying the Thr92Ala-DIO2 polymorphism and may explain why some clinical studies performed in different populations across the globe have obtained inconsistent results.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Section of Adult and Pediatric Endocrinology, Diabetes & Metabolism, University of Chicago Medical Center, Chicago, IL 60637, USA.
- Department of Pharmacology, Biomedical Science Institute, University of São Paulo, São Paulo 05508, Brazil.
- Human Developmental Sciences Graduate Program, Center for Biological and Health Sciences, Presbyterian Mackenzie University, São Paulo, SP 01302, Brazil.
ORCID-Profile: Alice Batistuzzo, Antonio C Bianco
Förderung
- NIDDK NIH HHS
- Fundação à Pesquisa do Estado de São Paulo
- PROEX
- National Institute of Diabetes and Digestive and Kidney Diseases
Zitieren
APA
Gabriel de Almeida, G., Bolin, A. P., Batistuzzo, A., Fonseca, T. L., Ribeiro, M. O., & Bianco, A. C. (2024). Genetic Background Strongly Influences the Impact of Carrying the Thr92Ala-DIO2 Polymorphism in the Male Mouse. Endocrinology. https://doi.org/10.1210/endocr/bqae064
Vancouver
Gabriel de Almeida G, Bolin AP, Batistuzzo A, Fonseca TL, Ribeiro MO, Bianco AC. Genetic Background Strongly Influences the Impact of Carrying the Thr92Ala-DIO2 Polymorphism in the Male Mouse. Endocrinology. 2024. doi:10.1210/endocr/bqae064
BibTeX
@article{GabrieldeAlmeida2024,
author = {Gabriel de Almeida, Guilherme and Bolin, Anaysa P and Batistuzzo, Alice and Fonseca, Tatiana L and Ribeiro, Miriam O and Bianco, Antonio C},
title = {Genetic Background Strongly Influences the Impact of Carrying the Thr92Ala-DIO2 Polymorphism in the Male Mouse},
journal = {Endocrinology},
year = {2024},
doi = {10.1210/endocr/bqae064}
}
EUVIMED